Editorial
doi: 10.1136/bmj.d7282.
Glucagon-like peptide-1 agonists
- PMID: 22236410
- DOI: 10.1136/bmj.d7282
Item in Clipboard
Editorial
Glucagon-like peptide-1 agonists
BMJ.
.
No abstract available
Comment on
-
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.BMJ. 2012 Jan 10;344:d7771. doi: 10.1136/bmj.d7771. BMJ. 2012. PMID: 22236411 Free PMC article.
Similar articles
-
GLP-1R agonists are not a quick fix for weight loss.BMJ. 2012 Feb 28;344:e1455; author reply e1459. doi: 10.1136/bmj.e1455. BMJ. 2012. PMID: 22374905 No abstract available.
-
Utility of GLP-1R agonists in diabetes requires long term study.BMJ. 2012 Feb 28;344:e1451; author reply e1459. doi: 10.1136/bmj.e1451. BMJ. 2012. PMID: 22374904 No abstract available.
-
Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats.Obesity (Silver Spring). 2011 Jul;19(7):1342-9. doi: 10.1038/oby.2011.50. Epub 2011 Mar 17. Obesity (Silver Spring). 2011. PMID: 21415845
-
Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.Expert Opin Pharmacother. 2014 Dec;15(17):2487-500. doi: 10.1517/14656566.2014.965678. Epub 2014 Sep 26. Expert Opin Pharmacother. 2014. PMID: 25260877 Review.
-
Liraglutide in the treatment of obesity.Expert Opin Biol Ther. 2014 Aug;14(8):1215-24. doi: 10.1517/14712598.2014.925870. Epub 2014 Jun 6. Expert Opin Biol Ther. 2014. PMID: 24905058 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
